BRAF and melanoma: AMPK activators phenformin and AICAR were shown to inhibit the cell growth of both BRAF-mutant or NRAS-mutant melanoma cell, due to cell-cycle arrest in either the G0/G1 or the S phase, associated with an increased expression of the p21 cell-cycle inhibitor (60).